Neuroprotective roles of the P2Y2 receptor

被引:0
作者
Gary A. Weisman
Deepa Ajit
Richard Garrad
Troy S. Peterson
Lucas T. Woods
Christina Thebeau
Jean M. Camden
Laurie Erb
机构
[1] University of Missouri,Department of Biochemistry
[2] University of Missouri,Interdisciplinary Neuroscience Program
[3] University of Missouri,Christopher S. Bond Life Sciences Center
[4] Missouri State University,Biomedical Sciences Department
来源
Purinergic Signalling | 2012年 / 8卷
关键词
P2Y; receptor; CNS; P2X and P2Y receptors;
D O I
暂无
中图分类号
学科分类号
摘要
Purinergic signaling plays a unique role in the brain by integrating neuronal and glial cellular circuits. The metabotropic P1 adenosine receptors and P2Y nucleotide receptors and ionotropic P2X receptors control numerous physiological functions of neuronal and glial cells and have been implicated in a wide variety of neuropathologies. Emerging research suggests that purinergic receptor interactions between cells of the central nervous system (CNS) have relevance in the prevention and attenuation of neurodegenerative diseases resulting from chronic inflammation. CNS responses to chronic inflammation are largely dependent on interactions between different cell types (i.e., neurons and glia) and activation of signaling molecules including P2X and P2Y receptors. Whereas numerous P2 receptors contribute to functions of the CNS, the P2Y2 receptor is believed to play an important role in neuroprotection under inflammatory conditions. While acute inflammation is necessary for tissue repair due to injury, chronic inflammation contributes to neurodegeneration in Alzheimer’s disease and occurs when glial cells undergo prolonged activation resulting in extended release of proinflammatory cytokines and nucleotides. This review describes cell-specific and tissue-integrated functions of P2 receptors in the CNS with an emphasis on P2Y2 receptor signaling pathways in neurons, glia, and endothelium and their role in neuroprotection.
引用
收藏
页码:559 / 578
页数:19
相关论文
共 1449 条
  • [1] Burnstock G(2007)Physiology and pathophysiology of purinergic neurotransmission Physiol Rev 87 659-797
  • [2] Sak K(2002)A retrospective of recombinant P2Y receptor subtypes and their pharmacology Arch Biochem Biophys 397 131-136
  • [3] Webb TE(2004)Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine J Biol Chem 279 19790-19799
  • [4] Inbe H(2006)International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy Pharmacol Rev 58 281-341
  • [5] Watanabe S(1998)Salivary gland nucleotide receptors: evidence for functional expression of both P2X and P2Y subtypes Eur J Morphol 36 170-175
  • [6] Miyawaki M(2006)P2 receptors in health and disease Biotechnol Genet Eng Rev 22 171-195
  • [7] Tanabe E(2006)P2 receptors: intracellular signaling Pflugers Arch 452 552-562
  • [8] Encinas JA(1996)Purinergic receptors: their role in nociception and primary afferent neurotransmission Curr Opin Neurobiol 6 526-532
  • [9] Abbracchio MP(1996)Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells Trends Neurosci 19 13-18
  • [10] Burnstock G(2004)Molecular physiology of P2 receptors in the central nervous system Eur J Pharmacol 483 5-17